Skip to content

Comparison the effect of pretreatment with lbuprofen, Indomethacin, and placebo on the success of inferior alveolar nerve block for teeth with irreversible pulpitis

Comparison the effect of pretreatment with lbuprofen, Indomethacin, and placebo on the success of inferior alveolar nerve block for teeth with irreversible pulpitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138803192016N1
Enrollment
150
Registered
2010-02-20
Start date
2009-09-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Teeth with irreversible pulpitis. Diseases of pulp and periapical tissues

Interventions

Intervention 1: Ibuprofen, 1 capsule of 600 mg, 1 hour before the local anesthetic injection. Intervention 2: Indomethacin, 1 capsule of 75 mg, 1 hour before the local anesthetic injection. Interventi
Treatment - Drugs
Placebo
Ibuprofen, 1 capsule of 600 mg, 1 hour before the local anesthetic injection
Indomethacin, 1 capsule of 75 mg, 1 hour before the local anesthetic injection

Sponsors

Oral and Dental Resrach Center and Vice-Chancellor for Research, Kerman University of Medical Scienc
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age more than 18 years, no contraindications to taking either Ibuprofen or Indomethacin (history of any allergic reaction to aspirin, NSAIDS, or Lidocaine with Epinephrine, nasal polyp, history of peptic ulcers or GI bleeding, pregnancy and lactation, renal or hepatic disease), no history of GI disorders or ulcer, having no serious systemic disease. Exclusion criteria: no response to cold test, having sensitivity to percussion and palpation, having radiographic changes such as PDL widening, lack of vital pulp in coronal pulp chamber access cavity preparation, teeth with evidence of crack in their crown, having advanced periodontal disease, taking narcotic drugs or analgesic drugs in recent 12 hours before treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Response to cold test. Timepoint: 1 hour after taking drug. Method of measurement: using cold spray.

Secondary

MeasureTime frame
Pain. Timepoint: After injection of local anesthesia and during treatment. Method of measurement: using visual analoug scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNozar Nakhaee

Kerman University of Medical Sciences

nakaeen@yahoo.com+98 34 1226 3815

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026